CCL2 and neoplasm: Importantly, higher CCL2 scores as determined by immunohistochemistry were more frequently seen in brain metastatic tissue than in matched primary tumor tissue and additionally CCL2 expression correlated with PTEN loss in brain metastatic tissue (37).